tiprankstipranks
Trending News
More News >
StemCell Institute (JP:7096)
:7096
Japanese Market

StemCell Institute (7096) Income Statement

Compare
0 Followers

StemCell Institute Income Statement

Last quarter (Q3 2024), StemCell Institute's total revenue was ¥667.00M, a decrease of -0.65% from the same quarter last year. In Q3, StemCell Institute's net income was ¥68.00M. See StemCell Institute’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 2.68B¥ 2.48B¥ 2.09B¥ 1.78B¥ 1.41B
Gross Profit
¥ 1.69B¥ 1.58B¥ 1.34B¥ 1.11B¥ 924.21M
Operating Expenses
¥ 1.27B¥ 1.16B¥ 1.04B¥ 884.30M¥ 837.33M
Depreciation and Amortization
¥ 128.28M¥ 120.59M¥ 104.93M¥ 96.91M¥ 32.78M
EBITDA
¥ 695.19M¥ 534.00M¥ 383.89M¥ 309.47M¥ 119.66M
Operating Income
¥ 418.51M¥ 413.76M¥ 297.56M¥ 226.95M¥ 86.88M
Other Income/Expenses
¥ 147.20M¥ 27.57M¥ -18.60M¥ -14.40M¥ 4.57M
Pretax Income
¥ 565.71M¥ 441.33M¥ 278.96M¥ 212.55M¥ 91.45M
Net Income
¥ 385.80M¥ 310.98M¥ 198.03M¥ 133.73M¥ 62.37M
Per Share Metrics
Basic EPS
¥ 37.67¥ 30.25¥ 19.33¥ 13.20¥ 6.41
Diluted EPS
¥ 37.67¥ 30.25¥ 19.33¥ 13.20¥ 6.41
Weighted Average Shares Outstanding
10.24M 10.25M 10.25M 10.13M 9.73M
Weighted Average Shares Outstanding (Diluted)
10.24M 10.25M 10.25M 10.13M 9.73M
Currency in JPY

StemCell Institute Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis